Literature DB >> 21306323

Trends in incidence of borderline ovarian tumors in Denmark 1978-2006.

Charlotte Gerd Hannibal1, Lene Drasbek Huusom, Anette Kjaerbye-Thygesen, Ann Tabor, Susanne K Kjaer.   

Abstract

OBJECTIVE: To examine period-, age- and histology-specific trends in the incidence rate of borderline ovarian tumors in Denmark in 1978-2006.
DESIGN: Register-based cohort study.
SETTING: Denmark 1978-2006. POPULATION: 5079 women diagnosed with a borderline ovarian tumor in at least one of two nationwide registries (4312 epithelial tumors and 767 non-epithelial/unspecified tumors).
METHODS: Estimation of overall incidence rates and period-, age- and histology-specific incidence rates. Age-adjustment was done using the World Standard POPULATION. To evaluate incidence trends over time, we estimated average annual percentage change and 95% confidence intervals (CI) using log-linear Poisson models. MAIN OUTCOME MEASURES: Age-standardized and age-specific incidence rates and average annual percentage change.
RESULTS: The incidence of epithelial borderline ovarian tumors increased from 2.6 to 5.5 per 100,000 women-years between 1978 and 2006, with an average annual percentage change of 2.6% (95% CI: 2.2-3.0). The median age at diagnosis was 52 years. Women 40 years or older had a higher average annual percentage change than women younger than 40 years. Most tumors were mucinous (49.9%) and serous tumors (44.4%). Women with mucinous tumors were younger at diagnosis (50 years) compared with women with serous tumors (53 years). Women with serous tumors had a higher average annual percentage incidence change than women with mucinous tumors.
CONCLUSIONS: The incidence rate of borderline ovarian tumors increased significantly in Denmark in 1978-2006. In line with results for ovarian cancer, Denmark had a higher incidence rate of borderline ovarian tumors compared with the other Nordic countries in 1978-2006.
© 2011 The Authors Acta Obstetricia et Gynecologica Scandinavica© 2011 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Mesh:

Year:  2011        PMID: 21306323     DOI: 10.1111/j.1600-0412.2010.01060.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  4 in total

1.  Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study.

Authors:  Koji Matsuo; Hiroko Machida; Brendan H Grubbs; Shinya Matsuzaki; Maximilian Klar; Lynda D Roman; Anil K Sood; David M Gershenson
Journal:  Gynecol Oncol       Date:  2020-01-15       Impact factor: 5.482

2.  Trends of low-grade serous ovarian carcinoma in the United States.

Authors:  Koji Matsuo; Hiroko Machida; Brendan H Grubbs; Anil K Sood; David M Gershenson
Journal:  J Gynecol Oncol       Date:  2018-01       Impact factor: 4.401

3.  Histologic distribution of borderline ovarian tumors worldwide: a systematic review.

Authors:  Taejong Song; Yoo-Young Lee; Chel Hun Choi; Tae-Joong Kim; Jeong-Won Lee; Duk-Soo Bae; Byoung-Gie Kim
Journal:  J Gynecol Oncol       Date:  2013-01-08       Impact factor: 4.401

Review 4.  The Diagnosis, Treatment, Prognosis and Molecular Pathology of Borderline Ovarian Tumors: Current Status and Perspectives.

Authors:  Yu Sun; Juan Xu; Xuemei Jia
Journal:  Cancer Manag Res       Date:  2020-05-19       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.